BMO's Kostas Biliouris: It will be challenging for the FDA to force a market withdrawal for Sarepta
Автор: CNBC Television
Загружено: 2025-07-21
Просмотров: 14294
Kostas Biliouris, BMO Capital Markets biotech analyst, joins CNBC's 'Squawk on the Street' to discuss the latest details on Sarepta after the company declined the FDA's request to halt shipments of its gene therapy.
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке: